Primecap Management CO Novartis Ag Call Options Transaction History
Primecap Management CO
- $134 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.24 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$824 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$711 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$588 Million0.87% of portfolio
-
Bank Of America Corp Charlotte, NC4.96MShares$506 Million0.05% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $219B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...